Idexx Laboratories (IDXX) Revenue (2009 - 2026)

Idexx Laboratories has reported Revenue for 18 years, with the latest figure at $1.2 billion in Q2 2026.

• On a quarterly basis, Revenue rose 9.66% year-over-year to $1.2 billion in Q2 2026; TTM through Jun 2026 was $4.6 billion, a 12.77% increase from a year earlier, with the FY2025 full-year figure at $4.3 billion, up 10.42% from the prior year.
• Revenue was $1.2 billion for Q2 2026 at Idexx Laboratories, up from $1.1 billion in the prior quarter.
• The five-year high for Revenue was $1.2 billion in Q2 2026, with the low at $828.6 million in Q4 2022.
• Average Revenue over 5 years is $977.0 million, with a median of $959.2 million recorded in 2024.
• The sharpest annual moves came in 2022 and 2025: Revenue grew 3.43% in 2022, then gained 14.28% in 2025.
• Over 5 years, Revenue stood at $828.6 million in 2022, then grew by 8.81% to $901.6 million in 2023, then advanced by 5.84% to $954.3 million in 2024, then grew by 14.28% to $1.1 billion in 2025, then increased by 11.55% to $1.2 billion in 2026.
• The last three Revenue figures came in at $1.2 billion (Q2 2026), $1.1 billion (Q1 2026), and $1.1 billion (Q4 2025), per Business Quant data.